NDA Partners LLC: A Development Partner to Biopharmaceutical Investors and Companies

Sami Karaborni, PhD

Practice Area Focus

  • Drugs
  • CMC
  • Manufacturing


Dr. Sami Karaborni joined NDA Partners as an Expert Consultant in 2017. Dr. Karaborni is an expert in product and process development of new chemical entities (NCEs) and various dosage forms. Over his impressive 20-year career in the pharmaceutical and chemical industries, he served in several senior executive positions including Vice President of Development Operations and Executive Director of Preformulations and Formulation Development at XenoPort Inc. At XenoPort, he led multiple groups active in the areas of chemical, analytical, bioanalytical, formulation development, supply chain and commercial manufacturing.

He was Director of Pre-clinical Development Technology, Director of Materials Characterization and Technology Assessment, and Director of Formulation Design and Characterization at Merck Research Labs. In his early career, he was Senior Research Engineer for the Royal Dutch Shell company in Amsterdam, The Netherlands.

Dr. Karaborni is a member of the advisory board of the Surfactant Science series and inventor of 19 US published patents and patent applications.

Dr. Karaborni is the (co)author of more than 40 publications in international journals among which Science (Washington), Nature (London), La Recherche Scientifique (Paris) and Mundo Científico (Madrid). He has been a key speaker in several conferences among which Gordon Conferences (USA), Royal Society of Chemistry (Great Britain) and Rencontres de Moriond (Switzerland).